Omics and Life Science Tools Stocks Dampened by Broader Market in August | GenomeWeb

NEW YORK (GenomeWeb News) – The GenomeWeb Daily News Index slid about 2 percent in August, mirroring the decline in the broader market.

During the month, 19 of the 30 firms comprising the Index saw their month-over-month share prices retreat, led by Nanosphere, which was down almost 34 percent. Vermillion (-20 percent), NanoString Technologies (-16 percent) and Exact Sciences (-16 percent) were also down significantly during the month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.